Error: Could not add to watchlist. X

Isis Pharmaceuticals Inc

+ Watchlist
ISIS:US
NASDAQ GS
55.30
USD
1.34
2.48%
As of 20:10:00 ET on 08/05/2015.
Open
54.18
Day Range
53.25 - 56.13
Volume
1,951,948
Previous Close
53.96
52Wk Range
29.17 - 77.80
1 Yr Return
71.15%
Open
54.18
Day Range
53.25 - 56.13
Volume
1,951,948
Previous Close
53.96
52Wk Range
29.17 - 77.80
1 Yr Return
71.15%
YTD Return
-10.43%
Current P/E Ratio (TTM)
179.85
Earnings per Share (USD) (TTM)
0.31
Market Cap (b USD)
6.620
Shares Outstanding (m)
119.713
Price/Sales (TTM)
21.08
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.
ADDRESS
1896 Rutherford Road
Carlsbad, CA 92008-7326
United States
PHONE
1-760-931-9200
  • Stanley T Crooke "Stan"
    Chairman/President/CEO/Founder
  • B Lynne Parshall
    COO/Secretary
  • Sarah Boyce
    Chief Business Officer
  • Elizabeth L Hougen
    Senior VP:Finance/CFO
  • Patrick R O'Neil
    Senior VP:Legal/Gen Counsel
Show More